Published in Volume
97, Issue 12 (June 15, 1996)
J Clin Invest. 1996;97(12):2872–2877.
doi:10.1172/JCI118744.
Copyright ©
1996, The American Society for
Clinical Investigation.
Research Article
Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.
T J Liang, A E Reid, R Xavier, R D Cardiff and T C Wang
Department of Medicine, Massachusetts General Hospital, Boston 02114, USA. liangt@bdg.niddk.nih.gov
Published June 15, 1996
Receptor tyrosine kinases are important in cell signal transduction and proliferation. Abnormal expression of tyrosine kinases often leads to malignant transformation. C-met is a tyrosine kinase receptor and its ligand is hepatocyte growth factor (HGF). HGF/c-met plays diverse role in regulation of cell growth, shape and movement. Constitutively activated met, such as tpr-met, is a potent oncogene in vitro, but its carcinogenic role in vivo remains unclear. Our study demonstrates that expression of tpr-met leads to development of mammary tumors and other malignancies in transgenic mice, and suggests that deregulated met expression may be involved in mammary carcinogenesis.